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Background: Oral squamous cell carcinoma (OSCC) is the most frequently occurring malignant 
tumour in the oral cavity. OSCC arises because of multiple genetic alterations. Cell cycle aberrations 
and aneuploidy are reportedly among the main characteristics of cancer cells and are associated 
with aggressive growth and poor prognosis. 
Methods: The study sample included 47 non-metastasised (NM) and 39 metastasised (M) primary 
OSCC, with matched positive cervical lymph nodes (LN) and 17 normal oral mucosa (NOM) samples. 
Tissue microarrays (TMAs) were prepared with a minimum of three cores from each case. TMA 
sections were cut and immunostained with MCM2, Ki-67, geminin and cyclin D1 antibodies. DNA 
image analysis was performed on the whole tissue section before TMAs were created.  
Results: The results revealed that there were no differences in cell cycle protein expression in 
different areas of the tumours or between the metastatic and non-metastatic carcinomas. None of 
the cell cycle proteins showed significant differences between the lymph node metastasis and the 
primary OSCC, except for Ki-67. Geminin/Ki-67 ratio showed significant difference between 
metastatic and non-metastatic tumours. Aneuploidy was detected in all (100%) cases of OSCC. 
Similarly, all lymph node samples (39 cases) were aneuploid. 
Conclusion: The results suggest that although there was dysregulation of cell cycle regulatory 
proteins, only Ki-67 and the MCM2/Ki-67 and geminin/Ki-67 ratios may have prognostic significance 
in oral cancer. DNA ploidy alone was not specific and may not be a good tool to evaluate prognosis 
or metastatic progression in oral cavity carcinomas. 
 
Introduction   
Squamous cell carcinoma comprises more than 90% of all malignancies in the oral cavity (1) and are 
characterised by a high rate of recurrence and metastasis to regional lymph nodes, with a 50% 
mortality rate (2). Nodal metastasis is considered to be a significant prognostic indicator (3).  
Several studies have reported the clinical utility of cell cycle proteins as a diagnostic predictor of oral 
carcinoma transformation (4, 5). However, few studies have evaluated the regulatory cell cycle 
proteins in primary lesions along with their lymph node metastases (6, 7)  
Oral squamous cell carcinoma (OSCC) arises as a consequence of multiple genetic alterations, which 
may cause cell dysregulation including alterations in cell cycle proteins, which contribute to the 
development and progression of lesions. Therefore, understanding of the biologic basis of these 
alterations is essential for proper diagnostic and prognostic evaluation.  
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Among the cell cycle regulators, minichromosome maintenance proteins (MCM2-7) are required for 
DNA replication and cell cycle initiation (8). MCM2 in particular has been proposed as a sensitive 
prognostic marker that may indicate the presence of an increased growth fraction in malignant 
lesions. The MCM2/Ki-67 ratio has been used as a prognostic parameter to estimate the population 
of cells that are licensed to proliferate (4). A high ratio indicates that many cells are in cycle, and 
could indicate a poor prognosis (9). Geminin is a proliferation marker expressed only during the S-
G2-M transition. It is believed to regulate cell cycle initiation by preventing the second pre-RC 
assembly once replication has taken place (10). The geminin/Ki-67 ratio estimates the relative length 
of G1, where a short G1 phase will approximate to a ratio of 1, cells with a prolonged G1 will 
approximate to a ratio of 0 (11). A higher ratio, indicates a faster rate of cell division, and may be 
associated with a worse prognosis (4). Analysis of these biomarkers may provide prognostic 
information in OSCC and may help to predict which lesions are most likely to metastasise.  
Aneuploidy, as a measure of abnormal nuclear DNA content, is known to be an indicator of 
numerical chromosomal and DNA aberrations, and is associated with a high risk of recurrence (12, 
13). In addition, several studies have underlined biomarkers associated with aneuploidy in oral 
epithelial dysplasia with risk of malignant transformation (14-16). However, the prognostic 
importance of DNA ploidy in oral cancer remains uncertain. 
DNA image cytometry (ICM) is widely used as a diagnostic and prognostic method for quantification 
of DNA content by means of integrated optical density (IOD). Furthermore, ICM provides two 
established parameters that may be used as quantitative measures of DNA alterations: the DNA 
index (DI) and the percentage of cells that exceed 5c (5cER) (17).  
The purpose of this study was to evaluate cell cycle proteins (MCM2, Ki-67, geminin and cyclin D1) 
and DNA ploidy in metastatic and non-metastatic OSCC and to determine their potential as 
diagnostic or prognostic markers. 
 
Materials and methods 
Tissue Specimens 
The pathology records in the Unit of Oral and Maxillofacial Pathology, School of Clinical Dentistry, 
University of Sheffield, were reviewed to identify cases of OSCC that had or had not metastasised. 
Metastatic cases were defined as histologically proven metastatic lesions in a cervical lymph node. 
Only cases that had been treated by primary surgery were included; cases that received 
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radiotherapy before surgical removal were excluded. Disease stage was defined in accordance with 
the TNM classification by the International Union Against Cancer (18). A total of 125 samples from 
86 patients were included in this study, 47 cases of OSCC that had not metastasised (OSCC NM) and 
39 cases that had metastasised (OSCC M), as well as the 39 matched positive lymph node lesions 
(OSCC LN). Seventeen cases of normal oral mucosa (NOM) that histologically looked normal were 
used as a control group. Clinical features for all studied samples are summarised in Table 1. Ethical 
approval for the project was obtained from South Sheffield Research Ethics Committee 
(08/S0709/70). 
Immunohistochemical staining  
Tissue microarrays (TMA) of specimens were constructed using a Beecher manual micro-array 
system (The L.S. Starrett Company, USA). For each sample a haematoxylin and eosin-stained section 
was examined and representative areas of the tumour were selected and marked on the glass slide 
using a cytology slide marker (Nikon). Care was taken to select representative areas of tumour with 
minimal stroma, and avoiding areas of necrosis or ulcer. Three areas were sampled for each OSCC 
primary tumour (surface, middle and advancing front) and whenever possible three cores were 
taken from each of those three areas, giving a maximum of nine TMA cores per tumour. 
Four-micrometre (4µm) sections of the TMA paraffin blocks were cut and mounted on coated slides 
(Menzel Gläser, Germany). Sections were dewaxed and rehydrated in absolute alcohol. To inhibit 
endogenous peroxidase activity, sections were treated with freshly prepared hydrogen peroxide in 
methanol (3% Met OH) for 30 minutes at room temperature. Then, a heat-mediated antigen 
retrieval protocol was carried out using citrate buffer (pH 6.0) in a steamer, for 30 minutes, for 
antibodies against MCM2, Ki-67 and geminin. For antibodies to cyclin D1 Tris-EDTA buffer (pH 9.0) 
was used for 30 minutes. Sections were incubated for 60 minutes, with normal horse serum for 
mouse monoclonal antibodies, or goat serum for rabbit polyclonal antibodies. Primary antibodies 
were diluted and incubated at 4°C overnight with anti-MCM2 (Sigma, 1:1000), anti-Ki-67(MIB-1, 
Dako, 1:75), anti-geminin (ab12147, Abcam, 1:300) and anti-cyclin D1 (EP12, Dako, 1:100). The 
visualisation system was the Vectastain ABC standard kit (Vector laboratories, US) that includes 
incubation with secondary biotinylated antibody and with an appropriate substrate for 30 minutes 
each at room temperature. Positive staining was detected after 6 minutes incubation with Vector 
Novared (Vector Laboratories, US). Finally, the slides were rinsed twice with distilled water and then 
counterstained with Mayer`s haematoxylin before being dehydrated and mounted with low viscosity 
DPX mounting media.  
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In addition, all cases were stained with p16
INK4A
 (2D9A12, Abcam,1:500) to exclude human papilloma 
virus (HPV) associated lesions. Sections from a known HPV positive oropharyngeal carcinoma were 
used as a positive control to ensure antibody specificity for p16
INK4A
. Immunostaining of p16
INK4A 
was 
considered positive if there was strong and diffuse nuclear and cytoplasmic staining in more than 
70% of tumour cells (19, 20). 
Expression of each protein was quantified by cell counting. Ten high power fields (×400 
magnification) were identified using a stratified random sampling method. An eyepiece graticule was 
used to delineate the counting area. A cumulative mean technique was used to determine the 
minimum number of cells that must be counted. For each case, a total of 800 to1500 nuclei were 
counted and a labelling index (LI) was calculated  as follows: 
LI = (total number of positive cells / total number of cells counted per case) × 100 
DNA image cytometry 
DNA content was evaluated using the Automated Cellular Imaging System, ACIS III (Dako, Glostrup, 
Denmark) using whole tissue sections. Briefly, 7µm paraffin sections were cut and slides were 
stained with Feulgen-Schiff stain, following the manufacturer`s instructions (ScyTek Laboratories Kit, 
USA). The ACIS system automatically scans the slides at ×400 to produce a virtual microscopy image. 
Using a pre-set algorithm the system then identifies abnormal nuclei. The operator then reviews the 
image to select areas of tumour for analysis and to confirm visually that the selected cells meet the 
criteria for control cells or malignant cells. Unwanted cells, for example, incomplete sections of 
nuclei, overlapping nuclei or obvious cell debris can be selected and rejected. For each case, at least 
300 qualified malignant epithelial nuclei and approximately 50 control nuclei (lymphocytes) in the 
same tissue were selected. The optical dentisty of these nuclei was then measured by the system.   
Criteria for classification of DNA histograms 
High fidelity DNA histograms were evaluated according to the criteria described in previous studies 
(21-23). Ploidy was classified according to the value of the DNA optical index (DI) as follows: normal 
(diploid) (DI = 0.91.10), mild aneuploid (DI = 1.111.30), moderate aneuploid (DI = 1.311.80) and 
severe aneuploid (DI = >1.81). In the case of two peaks, the DI of the most prominent peak was 
considered. 
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Statistical analysis 
Statistical analyses were undertaken using SPSS software (Version 21.0). ANOVA and t-tests were 
used to compare the mean LI of MCM2, Ki-67, geminin and cyclin D1 protein between groups (NOM, 
NM, M). Paired t-tests were used to evaluate differences in protein expression between primary 
OSCC and their matched LN metastases. Non-parametric tests were used to compare the DI, 5cER 
and ploidy status between groups. Spearman correlation tests were used to determine whether 
primary lesions with metastases and OSCC differentiation correlated with ploidy status. A p-value 
less than 0.05 was considered statistically significant. The general linear model (GLM) of repeated 
measures analyses was used to evaluate the differences in the LI of all proteins (MCM2, Ki-67, 
geminin and cyclin D1) in every group. 
 
RESULTS 
The clinical features of the 86 cases are summarised in Table 1. The mean age of NOM was 51.6 
years (Standard deviation (SD) of 15.7). In the OSCC NM group the mean age was 63.86 years (SD = 
12.6) and was 61.7 (SD = 12.55) in the OSCC M group. The primary tumours (OSCC NM and M) were 
histopathologically graded according to the WHO criteria (24). Of the 47 OSCC NM samples, 21 (45%) 
were well differentiated, 20 (43%) moderately differentiated and 6 (13%) poorly differentiated. In 
the samples that metastasised, 13 (33%) were well differentiated, 20 (51%) moderately 
differentiated and 6 (15%) poorly differentiated. There was no difference in differentiation between 
the two groups. In the metastatic node samples (OSCC LN), 15 (38%) were well differentiated, 21 
(54%) were moderately differentiated and 3 (8%) were poorly differentiated. The single most 
common site for the tumours was the anterior (mobile) tongue. 
All samples in the OSCC M group were stage III or IV, with the majority (69%) in stage IV, whereas all 
the OSCC NM cases were stage III or less with only 36% stage III (Table 1). In 36 of the metastatic 
(OSCC LN) lesions, the presence or absence of extracapsular spread (ECS) was recorded in the 
pathology records. The results showed that 16 out of the 36 cases (44%) showed ECS, while 20 (56%) 
showed no spread.  
The p16
INK4A
 staining confirmed that all cases (NOM, OSCC M, OSCC NM and OSCC LN) were negative 
and therefore this cohort did not include any HPV associated lesions. 
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Expression of cell cycle proteins  
Expression of cell cycle proteins as determined by LI is shown in Table 2. The NOM samples showed 
positive nuclear staining for MCM2, Ki-67, geminin and cyclin D1 mainly in the basal cell layers. The 
NOM group had the lowest expression of MCM2, Ki-67 and geminin when compared with OSCC M 
and OSCC NM groups.  
In the carcinoma samples, all the cell cycle proteins measured showed higher expression in the 
suprabasal, as well as the basal layers (Figures 1-2). There were no differences in expression for any 
of the measured markers between the different areas of the carcinomas (data not shown). 
Therefore, the LI data from each of the three areas was aggregated to give a single LI for each case 
(Table 2).   
In all samples, expression of MCM2 was significantly higher than Ki-67 or geminin (GLM, p<0.001) 
(Table 2). MCM2 was also significantly higher in OSCC M (73.58) compared to NOM (60.09) (p=0.007, 
ANOVA), but there was no difference between metastatic (OSCC M) and non-metastatic (OSCC NM) 
lesions. Similarly, there were no significant differences between OSCC M and OSCC NM for Ki-67, 
geminin or cyclin D1 expression. 
The geminin/Ki-67 ratio was significantly increased in carcinomas compared to NOM, but was also 
significantly increased in metastatic lesions (OSCC M; 0.68) compared to non-metastatic lesions 
(OSCC NM; 0.66) (p = 0.02, t-test). There were no differences in the MCM2/Ki-67 ratios.  
Incidence and severity of aneuploidy 
The DNA ploidy data is summarised in Table 3. There were no significant differences in ploidy status 
between OSCC M and OSCC NM, nor any correlation with tumour grade or stage (data not shown). 
The ploidy status of primary lesions and their corresponding metastases were compared. In 23 cases 
(59%), the degree of aneuploidy was the same in both lesions. In 8 of the 39 cases (21%) there was 
more severe aneuploidy in the lymph node metastases than in the primary lesion, and in a further 8 
cases the changes were less severe. The ploidy parameters, DI and 5cER values, were significantly 
higher in the nodal metastases (OSCC LN) than in the primary carcinomas (OSCC M) (p = 0.05 and 
0.01 respectively) (Table 3). 
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Discussion  
MCM2 expression increased from normal through OSCC NM to OSCC M. The lower expression in 
NOM demonstrates that cells are in the G0 (not proliferating) or in G0G1 phase. This suggests that 
normal epithelial cells have a low and organised proliferation rate but with constant proliferative 
ability. These results are in line with previous reports (4, 23). The geminin/Ki-67 ratio can potentially 
estimate the length of G1. Cells with an increased geminin/Ki-67 ratio have a shorter G1 phase and a 
high rate of cell proliferation. The geminin/Ki-67, but not MCM2/Ki-67 ratio for OSCC M increased 
significantly when compared with OSCC NM samples. The geminin/Ki-67 ratio has been proposed as 
a prognostic marker in oligodendroglial tumours (11), and the significant differences in the 
geminin/Ki-67 ratio between OSCC NM and OSCC M, suggest an accelerated G1 phase in metastatic 
oral tumours, which may provide a potential parameter for prognostic assessment of OSCC. 
There was no difference in the cell cycle regulatory proteins between primary and matched lymph 
node metastases, except for Ki-67, with higher expression in primary tumours. Higher expression in 
the primary lesions than the lymph nodes may reflect a lower proliferative capacity of metastatic 
tumour cells (25). More interestingly, geminin/Ki-67 and MCM2/Ki-67 ratios were lower in the nodal 
metastases than in the primary lesions, and these differences were statistically significant. Further 
investigation will confirm whether these ratios are reliable markers of metastasis in OSCC. 
In contrast, MCM2 expression was greater in the nodal metastases, but with no statistical 
significance. Low Ki-67 and high MCM2in the nodal metastases may suggest that a large population 
of metastatic cells are in G0 phase, but have proliferative potential (licensed). High MCM2 may 
reflect a cell proliferation capacity of OSCC in nodal metastases and supports the idea that 
metastatic lesions may be better differentiated (26). However, no study has yet explored the 
proliferative activity of OSCC in lymph nodes. 
All OSCC cases (NM & M) were aneuploid (100%). This result differs from previous studies which 
have recorded a lower aneuploidy incidence in OSCC (22, 27). Such variation may be attributable to 
differences in methodology used in each study. In the present study, ICM was used on whole tissue 
sections, which has the advantage that tumour areas can be accurately selected, ensuring 
representative sampling and exclusion of non-tumour cells. Additionally, DNA ploidy is known to be 
heterogeneous within OSCC and the rate of abnormal content (aneuploidy) is higher when multiple 
samples are analysed in each tumour (28, 29). Likewise, all lymph node metastasis lesions showed 
DNA abnormalities with varying degrees of severity. DI and 5cER parameters were significantly 
higher in the metastatic lesions than primary carcinomas. This suggests aberrant or increased DNA 
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content in metastatic tumour cells. This could also indicate that cells with high levels of aneuploidy 
are more likely to metastasise and may be a characteristic of progressive disease.  
In contrast, other studies did not find any association between high aneuploid incidence and high 
metastasis rates (30). However, confirmatory studies on quantitative evaluation of DI and 5cER are 
needed if these parameters are to have any prognostic value. 
Alterations in cell cycle proteins, including licensing proteins and regulators, may contribute to the 
development and progression of OSCC. MCM2 showed an increase from normal through OSCC NM 
to OSCC M, indicating the presence of a high number of cells licensed to proliferate. This result 
suggests that MCM2 may provide useful information about the growth fraction in normal and 
malignant cells. However, MCM2 did not show any significant difference in OSCC with or without 
metastasis. In addition, the geminin/Ki-67, but not MCM2/Ki-67 ratio for OSCC M was significantly 
associated with nodal metastases. No significant associations between MCM2, Ki-67, geminin and 
cyclin D1 and the TNM stages, lymph node metastases or differentiation were found. All cases 
showed abnormal DNA content, so DNA ploidy alone may not be a good diagnostic tool to evaluate 
OSCC progression in the oral cavity. Although, abnormal DNA content may be a necessary feature of 
OSCC, it is not specific to progressive lesions. 
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Figure Legends 
 
Figure 1:  
Representative immuno-staining of MCM2 (A), Ki-67 (B), geminin (C), and cyclin D1 (D) proteins in 
samples of OSCC that did not metastasise (OSCC NM). All images are at ×200 magnification. 
 
Figure 2:  
Representative immuno-staining of MCM2 (A), Ki-67 (B), geminin (C), and cyclin D1 (D) proteins in 
samples of OSCC that did metastasise (OSCC M). All images are at ×200 magnification.  
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Table 1: Clinical features for all studied samples. 
 
Clinical features  
Number (%) in each group 
NOM 
(n = 17) 
OSCC NM 
(n = 47) 
OSCC M 
(n = 39) 
Mean age (years) 51.55 ± 15.71 63.86 ± 12.58 61.67 ± 12.55 
Gender    
Male 8 (47) 32 (70) 26 (67) 
Female 9 (53) 15 (30) 13 (33) 
Tumour grade    
Well -- 21 (45) 13 (33) 
Moderate - 20 (43) 20 (51) 
Poor - 6 (13) 6 (15) 
Tumour stage (TNM) 
I  15 (32) 0 
II  15 (32) 0 
III  17 (36) 8 (21) 
IV  0 27 (69) 
NA  - 4 (10) 
Total  47 39 
Tumour size stage    
pT1  15 (32) 7 (18) 
pT2  15 (32) 10 (26) 
pT3  17 (36) 4 (10) 
pT4  0 18 (46) 
Total  47 39 
NOM = Normal oral mucosa 
OSCC M = Oral squamous carcinoma that had metastases 
OSCC NM = Oral squamous carcinoma that did not metastasise 
Percentages (%) in brackets 
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Table 2: Mean and standard deviation of MCM2, Ki-67, geminin and cyclin D1 labelling index (LI) 
values, along with MCM2/Ki-67 and geminin/Ki-67 ratios for all groups 
 
 Labelling index (LI) 
 Mean (Standard deviation) 
 MCM2 Ki-67 Geminin Cyclin D1 Stat. GLM MCM2/Ki-67 
ratio 
Geminin/Ki-67 
ratio 
NOM  
(n = 17) 
60.09 
(16.46) 
47.16 
(21.43) 
27.34 
(5.97) 
58.99 
(6.55) 
p < 0.001 1.55 
(0.67) 
0.58 
(0.23) 
OSCC NM 
(n = 47) 
69.96 
(16.28) 
64.61 
(28.31) 
34.23 
(14.11) 
55.35 
(17.96) 
p < 0.001 1.35 
(1.00) 
0.66 
(0.27) 
OSCC M (n 
= 39) 
73.58 
(16.12) 
54.23 
(21.39) 
31.16 
(15.94) 
56.84 
(12.97) 
p < 0.001 1.58 
(0.84) 
0.68 
(0.30) 
ANOVA 
test 
p = 0.007 NS NS NS  NS NS 
t-test  
(OSCC M vs 
OSCC NM) 
*NS *NS *NS *NS  *NS p* = 0.02 
OSCC LN 
(n = 39) 
79.88 
(12.66) 
49.66 
(36.04) 
20.75 
(21.90) 
59.20 
(20.81) 
p < 0.001 1.27 
(0.43) 
0.31 
(0.30) 
Paired  
t-test 
p = 0.84 p = 0.03 p = 0.21 p = 0.27  p = 0.05 p = 0.01 
 
NOM = Normal oral mucosa, OSCC NM = Oral squamous carcinoma that did not metastasise, OSCC M = Oral squamous carcinoma that had 
metastases, OSCC LN = Lymph node metastases, Stat GLM = General linear mode  
NS = Not significant. Paired t-test between primary tumours (OSCC M) and their lymph node metastasis (OSCC LN) 
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Table 3: Incidence of DNA ploidy status, DI and 5cER in OSCC NM, OSCC M and OSCC LN 
 
Groups 
Mild 
aneuploid 
n (%) 
Moderate 
aneuploid 
n (%) 
Severe 
aneuploid 
n (%) 
DI 
Median 
(25%-75%) 
5cER 
Median 
(25%-75%) 
OSCC NM 
(n = 47) 
 
2 (4) 25 (53) 20 (43) 
1.63 
(1.441.91) 
5.06 
(2.6010.79) 
OSCC M 
(n = 39) 
0 21 (54) 18 (46) 
1.61 
(1.501.79) 
3.36 
(1.007.80) 
Chi-Square test p = 0.5 p = 0.82 p = 0.17 
 
OSCC LN 
(n = 39) 
0 21 (54) 18 (46) 
1.70 
(1.52.20) 
9.90 
(0.8315.70) 
Wilcoxon Signed 
Rank Test 
p = 0.2 p = 0.05 p = 0.01 
 
OSCC NM = Oral squamous cell carcinoma that had not metastasis. OSCC M = Oral squamous cell carcinoma that had metastasis. OSCC LN 
= Lymph node metastasis. DI = DNA index. 5cER = Number of cells that exceed 5c 
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